Related references
Note: Only part of the references are listed.Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia
Hideki Muramatsu et al.
BLOOD (2010)
Long-term survival after nonintensive chemotherapy in some juvenile myelomonocytic leukemia patients with CBL mutations, and the possible presence of healthy persons with the mutations
Kazuyuki Matsuda et al.
BLOOD (2010)
Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies
Christine O'Keefe et al.
BLOOD (2010)
Myeloid Leukemia Development in c-Cbl RING Finger Mutant Mice Is Dependent on FLT3 Signaling
Chozhavendan Rathinam et al.
CANCER CELL (2010)
Gain-of-function c-CBL mutations associated with uniparental disomy of 11q in myeloid neoplasms
Seishi Ogawa et al.
CELL CYCLE (2010)
Deregulated Intracellular Signaling by Mutated c-CBL in Myeloid Neoplasms
Seishi Ogawa et al.
CLINICAL CANCER RESEARCH (2010)
Novel Oncogenic Mutations of CBL in Human Acute Myeloid Leukemia That Activate Growth and Survival Pathways Depend on Increased Metabolism
Margret S. Fernandes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome
N. Shiba et al.
LEUKEMIA (2010)
Rapidly fatal myeloproliferative disorders in mice with deletion of Casitas B-cell lymphoma (Cbl) and Cbl-b in hematopoietic stem cells
Mayumi Naramura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mutations in CBL occur frequently in juvenile myelomonocytic leukemia
Mignon L. Loh et al.
BLOOD (2009)
E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease
Srinivasa Rao Bandi et al.
BLOOD (2009)
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms
Francis H. Grand et al.
BLOOD (2009)
CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes
Carola Reindl et al.
CLINICAL CANCER RESEARCH (2009)
Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies
Hideki Makishima et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1/CSF1R signaling abnormalities in the cell line GDM1
A. Chase et al.
LEUKEMIA (2009)
Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms
Masashi Sanada et al.
NATURE (2009)
Whole genome scanning as a cytogenetic tool in hematologic malignancies
Jaroslaw P. Maciejewski et al.
BLOOD (2008)
250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies
Andrew J. Dunbar et al.
CANCER RESEARCH (2008)
Flt3-dependent transformation by inactivating c-Cbl mutations in AML
Buelent Sargin et al.
BLOOD (2007)
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia
Michael A. Caligiuri et al.
BLOOD (2007)
Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation
Amy D. Hartman et al.
EXPERIMENTAL HEMATOLOGY (2006)
Regulating the regulator: negative regulation of Cbl ubiquitin ligases
PE Ryan et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses
CBF Thien et al.
BIOCHEMICAL JOURNAL (2005)
Cbl: Many adaptations to regulate protein tyrosine kinases
CBF Thien et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)